Educational use only. These statements have not been evaluated by the FDA. Nothing on this site is intended to diagnose, treat, cure, or prevent any disease. Supplements are not pharmaceuticals — always consult your healthcare provider before making changes to your diet, supplements, or care plan.

Intermittent Fasting (16:8) — Evidence-Based Food Profile | Designed Nutraceuticals

Supplement LibraryfoodCognitiveStrong evidence

Intermittent Fasting (16:8)

The 16:8 intermittent fasting protocol -- 16 hours fasted, 8-hour eating window -- is the most extensively studied fasting method, with strong clinical evidence for improving insulin sensitivity, reducing inflammation, promoting autophagy, supporting weight loss, and enhancing cognitive function. A 2026 Cochrane review confirmed improvements in weight and blood sugar control in type 2 diabetes, while noting that individual results vary and that the most dramatic molecular benefits of fasting emerge only after approximately 72 hours of complete caloric restriction.

20

Conditions studied

11

Documented benefits

Strong

Evidence level

Food

Classification

Evidence graded: 🟢 Human RCT/meta-analysis  ·  🟡 Observational/preliminary  ·  🔴 Preclinical/mechanistic. Mechanistic hypotheses and animal studies are distinguished from established clinical evidence throughout.
AI assisted in organizing and cross-referencing this research. How we use AI · Evidence grading methods
Strong evidence: Multiple high-quality randomised controlled trials and/or systematic reviews support this intervention.

Key Benefits

Evidence level:🟢 Strong / Established🟡 Moderate / Mixed🔴 Preliminary / Limited
  • Activates AMPK -- the master metabolic switch; mimics caloric restriction at the cellular levelEstablished
  • Promotes autophagy -- cellular self-cleaning process that removes damaged proteins and organelles; note that the deepest autophagy requires 24-72+ hours of fasting, not achievable with 16:8 aloneEstablished
  • Reduces fasting insulin and glucose -- improves insulin sensitivity by 20-31% in RCTs; 2026 Cochrane review confirms blood sugar benefits in type 2 diabetes with variable individual responseModerate evidence
  • Reduces inflammatory markers -- CRP, IL-6, TNF-alpha all significantly reduced in clinical trialsModerate evidence
  • Elevates BDNF -- brain-derived neurotrophic factor; supports neuroplasticity and memory consolidationEstablished
  • Increases ketone production -- alternative brain fuel; neuroprotective and anti-seizure at therapeutic levelsEstablished
  • Reduces LDL particle size and triglycerides -- cardiovascular risk reduction confirmed in multiple RCTsStrong evidence
  • Supports weight loss -- comparable to continuous caloric restriction with better lean mass preservationEstablished
  • Improves circadian rhythm alignment -- eating within daylight hours optimizes metabolic outcomesEstablished
  • Reduces oxidative stress -- fasting upregulates Nrf2 antioxidant pathwayEstablished
  • Emerging (2026): proteomics research shows even short daily fasting windows initiate protein-level changes in metabolism and immune signaling, though the most significant systemic shifts require multi-day fastingModerate evidence

Relevant Conditions

Amounts Studied in Research

Fast 16 hours daily; eat within an 8-hour window (e.g., 10am-6pm or 12pm-8pm). Begin with 12:12 and extend by 1 hour per week. Drink water, black coffee, or plain tea during fasting window. For deeper autophagy and the molecular benefits identified in 2026 proteomics research, periodic extended fasts (24-72 hours) are required in addition to daily 16:8.

Amounts shown are those investigated in published research or commonly referenced in nutritional literature. They are not universal prescriptions. Consult a healthcare provider before starting any supplement.

Cautions & Interactions

Not recommended for pregnant or breastfeeding women, those with a history of eating disorders, type 1 diabetics on insulin, or those on sulfonylureas without medical supervision. Women may do better with 14:10 to avoid cortisol dysregulation. The 2026 Cochrane review notes that results vary significantly among individuals with diabetes -- monitor blood glucose closely.

Tags

intermittent fasting16:8autophagyAMPKinsulin sensitivityketonesBDNFweight lossmetabolic healthCochrane review 2026

Get a personalized plan

See how Intermittent Fasting (16:8) fits your specific health profile and conditions.

Start free assessment

Explore supplements relevant to your health profile

Take the free assessment to identify which nutrients and supplements may be most relevant to your health goals and conditions.

Start Free Assessment

Reach people actively researching this topic

Designed Nutraceuticals attracts health-conscious readers looking for evidence-based nutrition guidance. Supplement brands, wellness companies, and functional medicine practitioners can place targeted ads on pages like this one.

See Advertising Options